Biotech Values

[ghmm]

I am long SRPT but don't think they are likely to be bought out unless Garabedian is no longer with the company. I just don't get the impression he would sell out and I doubt he'd even partner. I don't view either of these as positive qualities. I noticed in RNA's acquisition document there was a company that was in the bidding but wouldn't go much higher than the then current market cap. If I thought more of Garabedian I would have that that would have been a good move (try but not go too high). I have nothing material to base it on but I have a strong suspicion BMRN at least approached SRPT in the past 3+ years.